NEURO2022

Presentation information

Print

Oral

[4O05m1] Neurodegenerative Disorders 2

Sun. Jul 3, 2022 9:00 AM - 10:00 AM Room 5 (Conference Building B2 (Okinawa Convention Center))

Chair: Youichi Shinozaki (University of Yamanashi)

[4O05m1-01] Ethosuximide improves clinical and pathological phenotypes of SCA42 mouse model

*Masaki Okubo1, Hiroshi Doi1, Shunta Hashiguchi1, Misako Kunii1, Keita Takahashi1, Mikiko Tada1, Kenichi Tanaka1, Hideyuki Takeuchi1, Taro Ishikawa2, Fumiaki Tanaka1 (1. Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, 2. Department of Pharmacology, The Jikei University School of Medicine)

Keywords:SCA42, ethosiximide, T-type voltage-gated Calcium channel, purkinje cell

Abstract password authentication.
A password is required to view the full text of the abstract. Please enter the following password.

PW: Neuro2022

Password